DUBLIN, Ohio, Dec. 8 /PRNewswire-FirstCall/ -- The board of directors of Cardinal Health, Inc. , the leading provider of products and services supporting the health care industry, declared today the company’s 81st consecutive regular quarterly dividend. The dividend of $0.03 per common share, without par value, is payable on Jan. 15, 2005 to shareholders of record on Jan. 1, 2005.
In formal business at the company’s annual meeting of shareholders, also held here today, three board members were reelected to three-year terms. Those board members are George H. Conrades, chairman and chief executive officer of Akamai Technologies, Inc.; Robert L. Gerbig, retired chairman and chief executive officer of Gerbig, Snell/Weisheimer & Associates, Inc.; and Richard C. Notebaert, chairman and chief executive officer of Qwest Communications International Inc.
A company proposal to amend its Performance-Based Incentive Compensation Plan also passed, as did a non-binding shareholder proposal regarding the annual election of directors.
About Cardinal Health
Cardinal Health, Inc. ( http://www.cardinalhealth.com/ ) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals and medical, surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion. Cardinal Health is ranked No. 17 on the current Fortune 500 list and named one of the best U.S. companies by Forbes magazine for 2004.
Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health’s Form 10-K, Form 8-K and Form 10-Q reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships or changes to the terms of those relationships, changes in the distribution patterns or reimbursement rates for health care products and/or services, the results, consequences, effects or timing of any inquiry or investigation by any regulatory authority or any legal and administrative proceedings, the impact of previously announced restatements, and general economic and market conditions. Cardinal Health undertakes no obligation to update or revise any forward-looking statement.
Cardinal Health, Inc.
CONTACT: Media, Jim Mazzola +1-614-757-3690, orjim.mazzola@cardinal.com , or Investors, Jim Hinrichs, +1-614-757-7828, orjim.hinrichs@cardinal.com , both of Cardinal Health, Inc.
Web site: http://www.cardinal.com/